气态氧化物-康格勒尔组合用于防止体外生命支持系统中的血栓
Karthik Ramakrishnan1, Joel Turner2, Manan Desai1
1Division of Cardiovascular Surgery, Children's National Hospital, Washington, District of Columbia; Department of Surgery and Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
The Journal of surgical research
|October 11, 2023
概括
在羊羔模型中,气性氧化 (gNO) 和静脉注射Cangrelor的组合显示出在体外生命支持 (ECLS) 期间预防血栓形成的潜力. 然而,这种组合对先前存在的血块是无效的,这表明需要进行前化抗凝药.
科学领域:
- 心血管研究研究心血管研究
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
背景情况:
- 身体外生命支持 (ECLS) 电路容易发生血栓形成,需要有效的抗凝策略.
- 目前用于ECLS的抗凝血方法存在风险和局限性.
- 研究新的药理组合对于提高ECLS的安全性和有效性至关重要.
研究的目的:
- 评估气氧化 (gNO) 与静脉注射Cangrelor用于ECLS动物模型中的血栓形成预防的协同效果.
- 为了确定这种组合是否提供了与标准护理相比更好的药理选择,或者没有抗凝药.
主要方法:
- 十只新生羊羔接受了ECLS.
- 五只羔羊接受了gNO和静脉注射Cangrelor的组合.
- 五只羔羊作为没有抗凝药的对照组.
- 主要终点:没有凝块形成的ECLS持续时间.
- 二级终点:最大的跨膜压力梯度.
主要成果:
- 实验组 (gNO + Cangrelor) 的平均ECLS持续时间为402分钟,而对照组 (P=0.17) 的平均持续时间为168分钟.
- 实验组中的两只羊羔在没有凝块形成的情况下支了长达12小时.
- 在实验组中,凝块形成发生在ECLS启动之前,在管放置后.
结论:
- 在干净的ECLS电路中,gNO和Cangrelor的组合有效地防止凝块形成.
- 当电路中已经存在血块时,这种组合是无效的.
- 未来的研究需要在注射前进行抗凝血剂的注射量和更大的样本大小.
相关概念视频
Pulmonary Embolism III: Nursing Management
15
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
192
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
192
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Antianginal Drugs: Nitrates and β-Blockers
609
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
609
Angina IV: Management
10
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
10
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11


